These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 28436233)

  • 21. Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis.
    Ingulli E; Singh A; Baqi N; Ahmad H; Moazami S; Tejani A
    J Am Soc Nephrol; 1995 Apr; 5(10):1820-5. PubMed ID: 7787150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis.
    Heering P; Braun N; Müllejans R; Ivens K; Zäuner I; Fünfstück R; Keller F; Krämer BK; Schollmeyer P; Risler T; Grabensee B;
    Am J Kidney Dis; 2004 Jan; 43(1):10-8. PubMed ID: 14712422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
    Gellermann J; Ehrich JH; Querfeld U
    Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis.
    Hamasaki Y; Yoshikawa N; Nakazato H; Sasaki S; Iijima K; Nakanishi K; Matsuyama T; Ishikura K; Ito S; Kaneko T; Honda M;
    Pediatr Nephrol; 2013 May; 28(5):765-71. PubMed ID: 23314441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of pulse methylprednisolone infusions with cyclosporine-based immunosuppression is safe and effective to treat recurrent focal segmental glomerulosclerosis after pediatric kidney transplantation.
    Shishido S; Satou H; Muramatsu M; Hamasaki Y; Ishikura K; Hataya H; Honda M; Asanuma H; Aikawa A
    Clin Transplant; 2013; 27(2):E143-50. PubMed ID: 23383697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children.
    Hattori M; Chikamoto H; Akioka Y; Nakakura H; Ogino D; Matsunaga A; Fukazawa A; Miyakawa S; Khono M; Kawaguchi H; Ito K
    Am J Kidney Dis; 2003 Dec; 42(6):1121-30. PubMed ID: 14655182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A partial response to abatacept in a patient with steroid resistant focal segmental glomerulosclerosis.
    Soyaltın E; Demir BK; Alparslan C; Çamlar SA; Alaygut D; Yavaşcan Ö; Mutlubaş F
    Turk J Pediatr; 2020; 62(4):663-667. PubMed ID: 32779421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical trial of focal segmental glomerulosclerosis in children and young adults.
    Gipson DS; Trachtman H; Kaskel FJ; Greene TH; Radeva MK; Gassman JJ; Moxey-Mims MM; Hogg RJ; Watkins SL; Fine RN; Hogan SL; Middleton JP; Vehaskari VM; Flynn PA; Powell LM; Vento SM; McMahan JL; Siegel N; D'Agati VD; Friedman AL
    Kidney Int; 2011 Oct; 80(8):868-78. PubMed ID: 21734640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants.
    Chun MJ; Korbet SM; Schwartz MM; Lewis EJ
    J Am Soc Nephrol; 2004 Aug; 15(8):2169-77. PubMed ID: 15284302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary FSGS in Nephrotic Adults: Clinical Profile, Response to Immunosuppression and Outcome.
    Bagchi S; Agarwal S; Kalaivani M; Bhowmik D; Singh G; Mahajan S; Dinda A
    Nephron; 2016; 132(2):81-5. PubMed ID: 26799973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose.
    Chishti AS; Sorof JM; Brewer ED; Kale AS
    Am J Kidney Dis; 2001 Oct; 38(4):754-60. PubMed ID: 11576878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing Kidney Health Outcomes in Children, Adolescents, and Adults With Focal Segmental Glomerulosclerosis.
    Gipson DS; Troost JP; Spino C; Attalla S; Tarnoff J; Massengill S; Lafayette R; Vega-Warner V; Adler S; Gipson P; Elliott M; Kaskel F; Fermin D; Moxey-Mims M; Fine RN; Brown EJ; Reidy K; Tuttle K; Gibson K; Lemley KV; Greenbaum LA; Atkinson MA; Hingorani S; Srivastava T; Sethna CB; Meyers K; Tran C; Dell KM; Wang CS; Yee JL; Sampson MG; Gbadegesin R; Lin JJ; Brady T; Rheault M; Trachtman H
    JAMA Netw Open; 2022 Aug; 5(8):e2228701. PubMed ID: 36006643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fifteen-year remission of a steroid-resistant nephrotic syndrome sustained by cyclosporine A.
    Drube J; Geerlings C; Taylor R; Mengel M; Ehrich JH
    Pediatr Nephrol; 2007 Apr; 22(4):600-2. PubMed ID: 17235550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of Different Immunosuppressive Regimen in Adult Biopsy Proven Idiopathic Focal Segmental Glomerulosclerosis: A Retrospective Analysis at a Single Center.
    Qureshi R; Nasir K; Imtiaz S; Dhrolia MF; Ahmad A; Salman B
    Saudi J Kidney Dis Transpl; 2022; 33(1):111-121. PubMed ID: 36647985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five-year follow-up study.
    Goumenos DS; Tsagalis G; El Nahas AM; Shortland JR; Davlouros P; Vlachojannis JG; Brown CB
    Nephron Clin Pract; 2006; 104(2):c75-82. PubMed ID: 16785738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical course of primary focal segmental glomerulosclerosis (FSGS) in Turkish children: a report from the Turkish Pediatric Nephrology FSGS Study Group.
    Beşbaş N; Ozaltin F; Emre S; Anarat A; Alpay H; Bakkaloğlu A; Baskin E; Buyan N; Dönmez O; Düşünsel R; Ekim M; Göko F; Gür-Güven A; Kavukçu S; Mir S; Sönmez F
    Turk J Pediatr; 2010; 52(3):255-61. PubMed ID: 20718182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Outcomes-Based Definition of Proteinuria Remission in Focal Segmental Glomerulosclerosis.
    Troost JP; Trachtman H; Nachman PH; Kretzler M; Spino C; Komers R; Tuller S; Perumal K; Massengill SF; Kamil ES; Oh G; Selewski DT; Gipson P; Gipson DS
    Clin J Am Soc Nephrol; 2018 Mar; 13(3):414-421. PubMed ID: 29167190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children.
    Raafat RH; Kalia A; Travis LB; Diven SC
    Am J Kidney Dis; 2004 Jul; 44(1):50-6. PubMed ID: 15211437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent Advances in Treatments of Primary Focal Segmental Glomerulosclerosis in Children.
    Han KH; Kim SH
    Biomed Res Int; 2016; 2016():3053706. PubMed ID: 27195285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.